Availability

Please contact us to check the availability

Specificity

-

Species reactivity

-

Product presentation

AGEs-BSA in PBS pH 7.4

Product category

Control Peptide

Antibody's raised in

-

Antibody's isotype

Antigen

Antibody's clone

-

Product is supplied as

liquid concentrate

Recommended concentration for use

1 ng/ml - 1 µg/ml

Protein concentration

1 mg/ml

Positive control

-

Pretreatment

-

Tested applications

ELISA, IHC, WB

Recommended secondary reagent

none

Storage method

Store at -20°C

UniProt number

Go to UniProt/SwissProt

Litterature

1. Takeuchi M. , Makita Z., Bucala R., Suzuki T., Koike T., and Kameda Y. (2000) Immunological evidence that non-carboxymethyllysine Advanced Glycation End-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol. Med. 6; 114-125. 2. Takeuchi M., Yanase Y., Matsuura N., Yamagishi S., Kameda Y., Bucala R., and Z. Matika (2001) Immunological detection of a novel Advanced Glycation End-Product. Mol. Med. 7; 783-791.

Tips

*Gentaur reagents are intended for in vitro research use only. They must not be used for clinical diagnostics and not for in vivo experiments in humans or animals.

Tissue

control

Description

Antigens are peptides or recombinant or native dependent on the production method.Isotype or positive controls by peptides, antibodies and deactivated samples.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.